Alkali metal-O2 batteries exhibit ultra-high theoretical energy density which is even on a par with to fossil energy and expected to become the next generation of energy storage devices. However,...
Nonaqueous lithium–oxygen
(Li–O2) batteries
have drawn the broad attention of researchers in recent years. A separator,
as an indispensable component of a battery, significantly affects
the electrolyte retention rate, ion conduction, and anode stability
in a Li–O2 battery. However, a comprehensive comparison
and analysis of the performance of commonly used separators in Li–O2 batteries are still lacking. In this study, systematic electrochemical
performances of Li–O2 batteries with five kinds
of commonly used separators Celgard 2400 (hereinafter referred to
as Celgard), Whatman GF/A, GF/D, GF/F, and a laboratory-made gel polymer
electrolyte (GPE) were investigated. Experimental results showed that
batteries with GF/D and GD/F separators had far more stable cycling
performances than those with GF/A, Celgard, and GPE, although the
batteries with Celgard and GPE displayed similar discharge and charge
capacity to the others. A slightly better cycling performance at the
current rate of 200 mA g–1 was obtained with GF/F
than with GF/D. Nevertheless, considering the much higher price of
GF/F than that of GF/D, the latter could be the best candidate for
validating the Li–O2 battery measurement. This study
provides researchers with a valuable reference for choosing suitable
separators for Li–O2 batteries from the perspectives
of cost and performance, which would push forward the process of the
practical application of Li–O2 batteries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.